DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS.
Eileen RakovitchSameer ParpiaAnne KochLaval GrimardHany SolimanChristiaan StevensFrancisco PereraIwa KongSenti SenthelalMargaret AnthesEricka WiebeJeffrey CaoMira GoldbergSally SmithLuciana SpadaforaTimothy J WhelanPublished in: Breast cancer research and treatment (2021)
The DCIS Score assay combined with CPFs identified more women with an estimated low (<10%) 10-yr LR risk after BCS, leading to a significant decrease in recommendations for RT compared to estimates based on CPFs alone.